KR890008565A - Hiv펩티드 및 hiv의 검출방법 - Google Patents
Hiv펩티드 및 hiv의 검출방법 Download PDFInfo
- Publication number
- KR890008565A KR890008565A KR1019880015398A KR880015398A KR890008565A KR 890008565 A KR890008565 A KR 890008565A KR 1019880015398 A KR1019880015398 A KR 1019880015398A KR 880015398 A KR880015398 A KR 880015398A KR 890008565 A KR890008565 A KR 890008565A
- Authority
- KR
- South Korea
- Prior art keywords
- lys
- arg
- peptide
- val
- hiv
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 31
- 238000001514 detection method Methods 0.000 title claims abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 9
- 238000000034 method Methods 0.000 claims abstract 5
- 239000012472 biological sample Substances 0.000 claims abstract 4
- 239000007790 solid phase Substances 0.000 claims 9
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 5
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 4
- 238000000576 coating method Methods 0.000 claims 4
- 238000003018 immunoassay Methods 0.000 claims 3
- 229940033330 HIV vaccine Drugs 0.000 claims 2
- 230000036436 anti-hiv Effects 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 210000000952 spleen Anatomy 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 238000007792 addition Methods 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (15)
- a)일반식 (Ⅰ)의 펩티드, b) 일반식(Ⅱ)펩티드, c)일반식Ⅲ)의 펩티드 및, d)일반식(Ⅳ)의 펩티드로 이루어진 그룹중에서 선택된 펩티드.(Ⅰ) Y-Tyr-Lys-Tyr-Lys-Val-Ile-Lys-Ile-Glu-Pro-Leu-Gly-Ile-Ala-Pro-Thr -Lys-Ala-Lys-Arg-Arg-Val-Val-Arg-Gln-Arg-Glu-Lys-Arg-X.(Ⅱ) Y-Arg-Asp-Asn-Trp-Arg-Ser-Glu-Leu-Tyr-Lys-Tyr-Lys-Val-Ile-Lys-Ile -Glu-Pro-Leu-Gly-Ile-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg-X.(Ⅲ)Y-Thr-Arg-Asp-Gly-Gly-Asn-Ser-Asn-Glu-Ser-Glu-Ile-Phe-Arg-Pro-Gly-Gly-Gly-Asp-Met-Arg-Asp-Asn-Trp-Arg-Ser-Glu-Leu-Tyr-Lys-Tyr-Lys-Val-Val-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg-X.(Ⅳ)Y-Arg-Ser-Glu-Leu-Tyr-Lys-Tyr-Lys-Val-Val-Lys-ILe-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg-Ala-Val-Gly-Ile-Gly-Ala-Leu-PHe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-X.상기 서열에서, Y는 -H, 아미노산, 펩티드, 단백질 또는 모든 링커이고, X는 -OH, -NH2, -NR1R2(여기서, R은 알킬그룹이다.), 펩티드, 단백질 또는 모든 링커이다.
- 펩티드 Ⅰ,Ⅱ,Ⅲ 및 Ⅳ, 및 이들의 치환, 결실 및 부가 동족체로 이루어진 그룹중에서 선택된 펩티드,
- 제2항에 있어서, 언급된 펩티드를 융합 단백질로서 HIV의 다른 에피토프와 조합하여 제조한 펩티드.
- 제2항에 있어서, HIV P24, gp41, gp120 및 이들의 조합물로 이루어진 그룹중에서 선택된 HIV항원과 조합된 펩티드.
- a)펩티드 Ⅰ,Ⅱ,Ⅲ 및 Ⅳ로 이루어진 그룹중 선택된 펩티드를 고체상에 피복시키고, b)고체상을 생물학적 샘플과 함께 배향하며, c)고체상을 검출용 표지로 표지됨 항-사람 Ig과 함께 배양하고, d)표지를 검출하여 생물학적 샘플중의 항-HIV존재를 측정함을 특징으로 하여, 생물학적 샘플중의 HIV항체를 검정하는 면역검정법.
- 제5항에 있어서, 공정 a)에서 고체상에 p24, gp41, 및 gp120, 및 이들의 조합물로 이루어진 그룹중에서 선택된 HIV항원을 추가로 피복시키는 면역검정법.
- 제5항에 있어서, 고체상이 a) 공정(a)에서 고체상에 제 3항의 펩티드를 피복시키고, b)항-사람 Ig를 항-사람 IgG, IgA, IgM 및 이들의 혼합물로 이루어진 그룹중에서 선택하며, c)검출용 표지를 효소, 방사능동위원소 및 형광분자로 이루어진 그룹중에서 선택하는, 특성중에서 독립적으로 선택된 하나이상의 특성을 갖는 면역검정법.
- a) 펩티드 Ⅰ,Ⅱ,Ⅲ 및 Ⅳ로 이루어진 그룹중에서 선택된 펩티드를 고체상에 피복시키고, b)고체상을 타액심플과 함께 배양하며, c)고체상을 검출용 표지로 표지된 항-사람 Ig와 함께 배양하고, d)표지를 검출하여 타액 샘플중의 항-HIV존재를 측정함을 특징으로 하여, 사람 타액 샘플중의 HIV항체를 검정하는 면역검정법.
- 제8항에 있어서, 고체상이 a) 공정(a)에서 고체상에 P24, gp41 및 gp120, 및 이들의 조합물로 이루어진 그룹중에서 선택된 HIV항원을 추가로 피복시키고, b)펩티드는 펩티드 Ⅲ이며, HIV항원은 p24 및 gp41이고, c)항-사람 Ig을 항-사람 IgG, Iga, IgM 및 이들의 혼합물로 이루어진 그룹중에서 선택하며, d)검출용 표지를 효서, 방사능동위원소 및 형광분자로 이루어진 그룹중에서 선택하는, 특성중에서 독립적으로 선택된 하나이상의 특성을 갖는 면역검정법.
- 적합한 보조제중에서 펩티드 Ⅰ,Ⅱ,Ⅲ,Ⅳ 및 이들의 혼합물로 이루어진 그룹중에서 선택된 펩티드로 동물을 면역시키고 동물을 혈청으로부터 항체를 수득함을 특징으로 하여, 제조된 HIV항체.
- 제10항에 있어서, 동물을 펩티드로 적어도 하나의 다른 HIV 항원과 조합하여 면역시킨 HIV 항체.
- 펩티드 Ⅰ,Ⅱ,Ⅲ,Ⅳ 및 이들의 혼합물로 이루어진 그룹중에서 선택된 면역화 용량의 펩티드를 동물에 주사하고, 동물로부터 비장을 분리한후, 비장을 골수종 세포와 융합시키고, 융합된 세포를 적합한 배양배지중에서 배양한후, 이 배양물로부터 HIV 항체를 수거함을 특징으로 하여, 제조된 HIV에 대한 모노클로날 항체.
- 제12항에 있어서, 동물을 적어도 하나의 다른 HIV 항원과 조합된 상태의 펩티드로 모노클로날 항체.
- 적합한 약제학적으로 허용되는 담체중에 펩티드 Ⅰ,Ⅱ,Ⅲ,Ⅳ 및 이들의 혼합물로 이루어진 그룹중에서 선택된 펩티드를 현탁시킴을 특징으로 하여, 제조된 HIV 백신.
- 제14항에 있어서, 펩티드가 적어도 하나의 다른 HIV 항원과 추가로 조합된 HIV 백신.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12480187A | 1987-11-24 | 1987-11-24 | |
US124,801 | 1987-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890008565A true KR890008565A (ko) | 1989-07-12 |
Family
ID=22416845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880015398A KR890008565A (ko) | 1987-11-24 | 1988-11-23 | Hiv펩티드 및 hiv의 검출방법 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0317804B1 (ko) |
JP (1) | JPH01165598A (ko) |
KR (1) | KR890008565A (ko) |
AT (1) | ATE128716T1 (ko) |
AU (1) | AU621317B2 (ko) |
CA (1) | CA1340157C (ko) |
DE (1) | DE3854550T2 (ko) |
ES (1) | ES2080047T3 (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1219232A (en) * | 1983-08-17 | 1987-03-17 | Richard A. Lerner | Polypeptide-induced monoclonal receptors to protein ligands |
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US4865966A (en) * | 1987-04-17 | 1989-09-12 | New York University | Method for detecting antibodies to human immunodeficiency virus |
JPH03271233A (ja) * | 1990-03-19 | 1991-12-03 | Inst Pasteur | ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発 |
US5876724A (en) * | 1990-03-19 | 1999-03-02 | Institut Pasteur | Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
JPH05506669A (ja) * | 1990-09-25 | 1993-09-30 | ペプテック (ユーケイ) リミテッド | エイズ治療法及びワクチン |
ES2257733T3 (es) * | 1991-08-29 | 2006-08-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Antigenos peptidicos multideterminantes que estimulan la respuesta de los linfocitos auxiliares al hiv en una amplia gama de humanos. |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6846905B2 (en) | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
US7736909B2 (en) | 2003-01-09 | 2010-06-15 | Board Of Regents, The University Of Texas System | Methods and compositions comprising capture agents |
DE102006012885A1 (de) * | 2006-03-18 | 2007-09-20 | Institut Virion/Serion Gmbh | Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial |
WO2010141421A1 (en) | 2009-06-02 | 2010-12-09 | The Board Of Regents Of The University Of Texas System | Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases |
WO2011047257A1 (en) | 2009-10-16 | 2011-04-21 | The Board Of Regents Of The University Of Texas System | Compositions and methods for producing cyclic peptoid libraries |
EA034031B1 (ru) * | 2011-01-06 | 2019-12-20 | Бионор Иммуно Ас | Димерный пептид для индуцирования иммунного ответа против hiv и его применение |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387914B1 (en) * | 1984-10-18 | 1993-08-04 | Institut Pasteur | Envelope antigens of the human immuno-deficiency virus, and their applications |
JPS61188356A (ja) * | 1985-02-18 | 1986-08-22 | Ricoh Co Ltd | 並列搬送型複写機 |
EP0212532A1 (en) * | 1985-08-12 | 1987-03-04 | Syntex (U.S.A.) Inc. | Method for producing fusion proteins |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
AU1711888A (en) * | 1987-04-24 | 1988-12-02 | Biogen, Inc. | Immunotherapeutic methods and compositions |
GB8714802D0 (en) * | 1987-06-24 | 1987-07-29 | Proteus Biotech Ltd | Synthetic polypeptides |
AU615670B2 (en) * | 1987-09-04 | 1991-10-10 | Murex Diagnostics Corporation | Immunoassay and biological constructs for use therein |
-
1988
- 1988-11-03 EP EP88118299A patent/EP0317804B1/en not_active Expired - Lifetime
- 1988-11-03 AT AT88118299T patent/ATE128716T1/de not_active IP Right Cessation
- 1988-11-03 ES ES88118299T patent/ES2080047T3/es not_active Expired - Lifetime
- 1988-11-03 DE DE3854550T patent/DE3854550T2/de not_active Expired - Fee Related
- 1988-11-17 AU AU25678/88A patent/AU621317B2/en not_active Ceased
- 1988-11-22 JP JP63295886A patent/JPH01165598A/ja active Pending
- 1988-11-22 CA CA000583731A patent/CA1340157C/en not_active Expired - Fee Related
- 1988-11-23 KR KR1019880015398A patent/KR890008565A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA1340157C (en) | 1998-12-01 |
ES2080047T3 (es) | 1996-02-01 |
ATE128716T1 (de) | 1995-10-15 |
EP0317804A2 (en) | 1989-05-31 |
EP0317804A3 (en) | 1990-09-12 |
AU2567888A (en) | 1989-05-25 |
EP0317804B1 (en) | 1995-10-04 |
AU621317B2 (en) | 1992-03-12 |
DE3854550D1 (de) | 1995-11-09 |
JPH01165598A (ja) | 1989-06-29 |
DE3854550T2 (de) | 1996-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1225590A (en) | Use of anti-idiotype antibodies in immunoassays | |
JP2624973B2 (ja) | エプスタイン・バーウイルス初期抗原(拡散)に関連する合成ポリペプチドおよび抗体 | |
US5086002A (en) | Erythrocyte agglutination assay | |
CA1190873A (en) | Recombinant monoclonal antibodies | |
KR890008565A (ko) | Hiv펩티드 및 hiv의 검출방법 | |
US5565319A (en) | Assay and apparatus for detecting feline immunodeficiency virus | |
US4654419A (en) | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen | |
KR930702387A (ko) | Hcv 펩티드-항원 및 c형 간염 바이러스(hcv)의 검사방법 | |
WO1999013907A3 (en) | Methods to improve immunogenicity of antigens and specificity of antibodies | |
KR970705026A (ko) | 다수의 항원을 사용하는 특이적 면역글로불린 결정 방법 | |
AU4439993A (en) | HCV peptide antigens and method of determining HCV | |
Perrin et al. | A modified rapid enzyme immunoassay for the detection of rabies and rabies-related viruses: RREID-lyssa | |
US4670384A (en) | Diagnostic reagent for swine trichinosis | |
Anders et al. | In vitro antibody response to influenza virus: I. T cell dependence of secondary response to hemagglutinin | |
US4689220A (en) | Immunization by immunogenic implant | |
KR880014376A (ko) | Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법 | |
Stocker et al. | Enzyme immunoassay for the detection of hybridoma products | |
Nielsen et al. | Monoclonal antibodies in veterinary medicine | |
Quesniaux et al. | An enzyme immunoassay for the screening of monoclonal antibodies to cyclosporin | |
EP0116949B1 (en) | Adult t cell leukemia associated cell strains and a method for the preparation of said strain and respective antiserum | |
KR890006672A (ko) | 재조합 htlv-ⅲ 단백질 및 이의 용도 | |
EP0308242A2 (en) | Agglutination assay | |
Dore et al. | Detection by ELISA of two tobamoviruses in orchids using monoclonal antibodies | |
US4767710A (en) | Cell lines for the production of monoclonal antibodies to human glycophorin A | |
WO2000073347A1 (en) | Diagnostic monoclonal antibody for yersinia pestis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |